Another Aussie CEO departs due to personal reasons
Company thanks boss for her “leadership and significant contribution" since 2002 in the latest exit following a string of CEO departures across Australia’s biotech sector
Company thanks boss for her “leadership and significant contribution" since 2002 in the latest exit following a string of CEO departures across Australia’s biotech sector
Medicinal cannabis patients in NSW will no longer have to choose between taking their medicine or driving after reforms abolish automatic license loss and heavy fines
In what's been described as the biggest industry transformation in 30 years, pharma is facing a 'commercialisation reset' on how it does business
A corporate and strategic communications advisory agency has buffed up its team with a former J&J and Novartis corporate affairs leader joining the ranks
Transforming Medical Information into a strategic source of intelligence for pharmas by unlocking more value from every scientific interaction
A harried Government has announced politically urgent PBS funding for a drug to replace one that is being pulled from the Scheme in November, following a patient backlash
After placing 43rd last year this pharma has blasted up the rankings to be named the world's fifth best company, trouncing industry rivals
Politicians are more likely cop flak than awards but the Health Minister has won a prestigious gong for his handling of an issue that's sparked a spat between patient groups
With a third of cardiac events being repeats, Amgen has co-authored a report to address gaps in post-hospital care
Judged on leadership, engagement, communication and employee benefits this Big Pharma has taken home a prestigious Australian HR award
ANZ General Manager among those being let go as “overlapping roles” are made redundant following a recent buyout
Two months on from the PBAC's July meeting, just over 60 per cent of the submissions recommended have started progressing towards a PBS listing
A LifeSciences Australia Summit has been told that HTA reforms which the Govt has been sitting on for more than five years are already out of date
After almost 10 years of legal wrangling over what has become the highest earning biosimilar referencing this one-time blockbuster, a loss for this Big Pharma
Another company has joined Medicines Australia as a Class 1 Member this month, with its ANZ chief revealing why it is a pivotal time for industry to speak up
Eight finalists tackling some of the most pressing challenges in health and medicine are in the running for funding to boost their research
Less than two years after leaving Australia, this former long-time ANZ GM has already won another promotion, stepping into an important role
One of the world's best known pharmaceutical companies is reportedly changing its name and introducing a new slogan
A series of ads claiming superiority over a competitor has ruffled feathers, with the companies landing in court despite agreeing to mediation
New data presented by two Sanofi staffers shows GPs hold the key to unlocking both clinical trial participation and representation across Australia
Nearly two in three young Australians believe employers should provide greater workplace support for people navigating fertility issues
Survey of Aussie GPs finds accuracy and hallucination risk is considered a "major concern" when it comes to AI yet eight in 10 are using it anyway
Pharma commissioned survey reveals low awareness about this chronic disease with symptoms often mistaken as stress associated with 'everyday living'
The company has updated its culture sharpening how it competes, works and delivers in a faster, more competitive market and there's more to come
New number-crunching has revealed that accepting Australia's notoriously low pricing for a medicine would cost a company more than an entire year's worth of local sales for that drug